Daniel Mirda, MD

Director

Dr. Daniel Mirda graduated cum laude from Cornell University majoring in chemistry/biochemistry. He obtained his medical degree from Stanford Medical School, where he explored basic science research, business courses at Stanford's Graduate School of Business and taught Stanford undergraduates human biology, while obtaining his medical degree. He then trained in Internal Medicine and received his specialty training in Oncology and Hematology at UCSF.

 

Dr. Mirda has extensive experience in basic science medical research, first conducting scientific research at Stanford University (1982-83) followed by UCSF (1988-1993) in the prestigious Howard Hughes Medical Institute. In 1993, he focused on clinical research and clinical medicine in the Napa Valley where his practice provides "state of the art" cancer therapies and clinical trials for his patients. He also organizes an annual meeting in Napa Valley with cancer specialists from UC Davis, UCSF and Stanford, reviewing the latest advances in cancer therapy. Dr. Mirda is associate editor for the national oncology journal (JOP), reviewing original articles on the "State of Cancer Care in America" (SOCCA). He is held in high esteem by his colleagues locally and nationally, as the preeminent cancer care specialist in Napa.

 

Dr. Mirda also advocates for cancer patients at the state and national level as President of the California Oncology/Hematology Society (ANCO), advising legislators in Sacramento and Washington DC about supporting cancer research and preserving access to cancer care for underserved populations. In his free time, Dr. Mirda enjoys golf, biking, hiking, skiing, windsurfing and spending time with family and friends.

 

Dr. Mirda hopes to contribute his expertise in basic science research and clinical research to advance the scientific achievements of NMRF and regenerative orthopedics.

dr-Mirda.jpg